Search | Page 34 | Aplastic Anemia and MDS International Foundation

Search

Search results

  1. Stem Cell Transplantation From HLA Partially-Matched Related Donors for Patients With Hematologic Malignancies

    ... the feasibility, efficacy and safety of hematopoietic stem cell transplantation (HSCT) from Human Leukocyte Antigen ( HLA ... Infusion (DLI) DLI containing 1 x 10E8/kg donor T-cells Biological: Haploidentical Stem Cell Transplantation 2-10 x ...

    Clinical Trial last updated 04/29/2016 - 10:59am.

  2. GVHD Prophylaxis With Post Transplant Cyclophosphamide for Patients With Renal Insufficiency Undergoing a Conventional 8/8 HLA-matched Related or Unrelated Donor Allogeneic Hematopoietic Stem Cell Transplant

    ... GVHD is one of the most common complications of a stem cell transplant . ... related or unrelated donor willing to donate stem cells . Exclusion ...

    Clinical Trial last updated 04/29/2016 - 12:40pm.

  3. Hildegard Greinix, MD

    ... Government to the European Commission's directives on stem cells and tissues and she has been an active participant of the NIH ...

    Bio last updated 03/11/2016 - 1:41pm.

  4. How long can I stay on cyclosporine?

    ... the T-lymphocytes are turned off, they stop attacking stem cells in the bone marrow . That means stem cells may be able to grow ...

    FAQ last updated 03/15/2016 - 11:49pm.

  5. Pacritinib in Combination With Low Dose Decitabine in Intermediate-High Risk Myelofibrosis or Myeloproliferative Neoplasm (MPN)/Myelodysplastic Syndrome (MDS)

    ... demonstrated depletion of DNMT1 in normal hematopoietic stem cells (HSC) without cytotoxicity and subcutaneous (SC) instead of ...

    Clinical Trial last updated 04/29/2016 - 1:59pm.

  6. Personalized Natural Killer (NK) Cell Therapy in Cord Blood Transplantation (CBT)

    ... this clinical research study is to learn if giving cells called natural killer (NK) cells after receiving 1 of 3 pre-treatment ... relapse (including relapse post autologous hematopoietic stem cell transplant ). Relapsed double hit lymphomas. Patients with options ...

    Clinical Trial last updated 06/06/2016 - 10:28am.

  7. Lukasz Gondek, M.D., Ph.D.

    ... Dezern on research related to signaling pathways in MDS stem cells . Dr. Gondek explained that the mechanism of progression in MDS is ...

    Bio last updated 03/11/2016 - 1:41pm.

  8. HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy (RAFA)

    ... plus a CD34+ selected T-cell depleted peripheral blood stem cell (PBSC) stem cell transplant for the treatment of patients ... Peripheral blood stem cell The source of stem cells for all patients will be peripheral blood stem cells (PBSC) induced and ...

    Clinical Trial last updated 04/28/2016 - 8:44am.

  9. Unrelated Donor Stem Cell Transplantation

    ... hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries. ...

    Clinical Trial last updated 04/28/2016 - 2:16pm.

  10. Unrelated Donor Stem Cell Transplantation

    ... hematopoietic progenitor cell transplantation using cells from unrelated individuals or cord blood registries. ...

    Clinical Trial last updated 04/27/2016 - 3:18pm.